Statement 4.2: CD patients who have undergone intestinal resection should be endoscopically assessed for intestinal inflammation 6–12 months after surgery, irrespective of their risk profile, and treatment decisions should consider this result. Evidence of mucosal inflammation is required for a diagnosis of CD recurrence, using endoscopy, cross-sectional imaging or biomarker tests (Evidence level 1b, 5)

Voting agreement rate 46/48 (95.8%)